Zelia Correa, MD, PhD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Castle Biosciences, Inc
    Topic:
    melanoma prognosis
    Date added:
    10/31/2024
    Date updated:
    10/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Ideaya Biosciences, Inc
    Topic:
    treatment uveal melanoma
    Date added:
    10/31/2024
    Date updated:
    10/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Aura Biosciences, Inc
    Topic:
    treatment small uveal melanoma
    Date added:
    10/31/2024
    Date updated:
    10/31/2024
Return to Ophthalmology at the Crossroads 2024 (RP2412D)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.